Yes because nothing would have changed since 2020 through the collegial discussions Mesoblast has had with the FDA in last 2+ years .... then of course insert Krause into the mix and the 4 year survival data to name a few but again you claim it is "everyone else that is getting it wrong" .... sounds almost akin to the claims you made about the supposed incorrect wording on a Mesoblast announcement to me and we all know how that worked out ?
ODAC August 2020 event materials, page-3
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.055(4.89%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.06 | $8.816M | 8.055M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 280000 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |